In May 2024, the clinical trials of an mRNA vaccine against which contagion has begun?

Clinical trials of an mRNA vaccine against influenza have begun.

Influensa kills up to 650,000 people around each year.

Existing influenza vaccines protect against specific strains only, requiring yearly updates due to virus mutations.

New mRNA vaccines offer broader, longer-lasting immunity by targeting multiple virus regions and triggering T-cell responses.

These vaccines use mRNA created in a laboratory to teach our cells how to make a protein.